ADAMTS-13 Inhibitors

The chemical class termed ADAMTS-13 Inhibitors encompasses a variety of compounds primarily characterized by their ability to modulate the activity of ADAMTS-13, an enzyme crucial for blood clotting homeostasis. These inhibitors do not directly target the enzyme but influence its activity by intervening in related biochemical pathways or cellular processes. The primary mechanism through which these chemicals exert their influence is by modulating the availability or functionality of essential metal ions. Many of these inhibitors, such as Zinc Chloride, EDTA, D-Penicillamine, and Disulfiram, function by chelating metal ions like zinc and copper, which are crucial for the metalloproteinase activity of ADAMTS-13. This chelation disrupts the structural integrity and enzymatic function of ADAMTS-13, leading to an indirect inhibition of its activity.

Another significant aspect of these inhibitors is their role in affecting the proteolytic function of ADAMTS-13. Compounds like Hydroxamic Acid, Phosphoramidon, Marimastat, and Batimastat are recognized for their ability to inhibit metalloproteinases. By targeting this specific domain of ADAMTS-13, these inhibitors can prevent the cleavage of vWF, thereby influencing blood clot formation. Doxycycline, although primarily known as an antibiotic, also falls into this category due to its metalloproteinase inhibiting properties. The inclusion of O-Phenanthroline and 1,10-Phenanthroline further emphasizes the role of metal ion chelation in modulating ADAMTS-13 activity. These compounds, by chelating zinc, can alter the enzyme's conformation and functionality.